Clinical Trials Directory

Trials / Completed

CompletedNCT02525315

Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Auditory hallucinations are common (present in 60-70% of cases) and extremely debilitating. Behavioral disorders associated with them can have serious social repercussions. However, in 25% of cases the usual antipsychotic drug treatments are incompletely or totally ineffective. Fifteen subjects will be included after collection and signed their informed consent. The rTMS treatment is made of 4 sessions of 13 minutes spread over two days, at a frequency of 20 Hz and an intensity of 80% of motor threshold at rest. These constants are used to stay below the risk of occurrence of seizures, the only serious side effects identified. Furthermore the rTMS treatment is almost painless: tension headaches are the main side effects and make amends with simple analgesics. rTMS is devoid of neurocognitive effects. The LEFT stimulation site will be established through a anatomofunctional imaging before treatment (between D-7 and D0). Treatment efficacy will be evaluated daily during treatment (days 1 and 2) and during the first 2 weeks of starting treatment.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial magnetic stimulation: rTMS4 sessions of 13 minutes, with 2 sessions a day, at 20Hz frequency and at an intensity of 80% of rest motor threshold will be delivered

Timeline

Start date
2007-06-01
Primary completion
2012-06-01
Completion
2013-12-01
First posted
2015-08-17
Last updated
2015-08-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02525315. Inclusion in this directory is not an endorsement.